Clinical Potential of Mesenchymal Stem Cell-Derived Exosomes in Bone Regeneration
Top Cited Papers
Open Access
- 29 June 2023
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (13) , 4385
Abstract
Bone metabolism is regulated by osteoblasts, osteoclasts, osteocytes, and stem cells. Pathologies such as osteoporosis, osteoarthritis, osteonecrosis, and traumatic fractures require effective treatments that favor bone formation and regeneration. Among these, cell therapy based on mesenchymal stem cells (MSC) has been proposed. MSC are osteoprogenitors, but their regenerative activity depends in part on their paracrine properties. These are mainly mediated by extracellular vesicle (EV) secretion. EV modulates regenerative processes such as inflammation, angiogenesis, cell proliferation, migration, and differentiation. Thus, MSC-EV are currently an important tool for the development of cell-free therapies in regenerative medicine. This review describes the current knowledge of the effects of MSC-EV in the different phases of bone regeneration. MSC-EV has been used by intravenous injection, directly or in combination with different types of biomaterials, in preclinical models of bone diseases. They have shown great clinical potential in regenerative medicine applied to bone. These findings should be confirmed through standardization of protocols, a better understanding of the mechanisms of action, and appropriate clinical trials. All that will allow the translation of such cell-free therapy to human clinic applications.Keywords
Funding Information
- Instituto de Salud Carlos III (PI18/01659, PI21/01935)
This publication has 167 references indexed in Scilit:
- miR-34s inhibit osteoblast proliferation and differentiation in the mouse by targeting SATB2Journal of Cell Biology, 2012
- Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cellsNature Communications, 2011
- Disorders of Bone RemodelingAnnual Review of Pathology: Mechanisms of Disease, 2011
- Physiology of Bone LossRadiologic Clinics of North America, 2010
- A microRNA regulatory mechanism of osteoblast differentiationProceedings of the National Academy of Sciences, 2009
- Functions of RANKL/RANK/OPG in bone modeling and remodelingArchives of Biochemistry and Biophysics, 2008
- Vascular biology and bone formation: hints from HIFJournal of Clinical Investigation, 2007
- The hypoxia-inducible factor α pathway couples angiogenesis to osteogenesis during skeletal developmentJournal of Clinical Investigation, 2007
- Ischemia leads to delayed union during fracture healing: A mouse modelJournal of Orthopaedic Research, 2006
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006